nyse:teva
|
5239
|
Mar 23rd, 2024 12:00AM
|
Teva Pharmaceuticals
|
1.1M
|
27867
|
Open
|
|
Mar 23rd, 2024 03:01AM
|
Mar 23rd, 2024 08:40PM
|
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/
|
Open
|
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
|
Open
|
124 Dvora hanevi'a
|
Tel-Aviv
|
|
IL
|
6944020
|
|
Teva
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:teva
|
5239
|
Mar 22nd, 2024 12:00AM
|
Teva Pharmaceuticals
|
1.1M
|
27867
|
Open
|
|
Mar 22nd, 2024 02:57AM
|
Mar 22nd, 2024 08:29PM
|
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/
|
Open
|
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
|
Open
|
124 Dvora hanevi'a
|
Tel-Aviv
|
|
IL
|
6944020
|
|
Teva
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:teva
|
5239
|
Mar 21st, 2024 12:00AM
|
Teva Pharmaceuticals
|
1.1M
|
27869
|
Open
|
|
Mar 21st, 2024 07:13PM
|
Mar 21st, 2024 07:13PM
|
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/
|
Open
|
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
|
Open
|
124 Dvora hanevi'a
|
Tel-Aviv
|
|
IL
|
6944020
|
|
Teva
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:teva
|
5239
|
Mar 20th, 2024 12:00AM
|
Teva Pharmaceuticals
|
1.1M
|
27864
|
Open
|
|
Mar 20th, 2024 04:07AM
|
Mar 20th, 2024 09:14PM
|
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/
|
Open
|
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
|
Open
|
124 Dvora hanevi'a
|
Tel-Aviv
|
|
IL
|
6944020
|
|
Teva
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:teva
|
5239
|
Mar 19th, 2024 12:00AM
|
Teva Pharmaceuticals
|
1.1M
|
27864
|
Open
|
|
Mar 19th, 2024 03:19AM
|
Mar 19th, 2024 07:48PM
|
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/
|
Open
|
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
|
Open
|
124 Dvora hanevi'a
|
Tel-Aviv
|
|
IL
|
6944020
|
|
Teva
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:teva
|
5239
|
Mar 18th, 2024 12:00AM
|
Teva Pharmaceuticals
|
1.1M
|
27865
|
Open
|
|
Mar 18th, 2024 03:07AM
|
Mar 18th, 2024 09:01PM
|
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/
|
Open
|
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
|
Open
|
124 Dvora hanevi'a
|
Tel-Aviv
|
|
IL
|
6944020
|
|
Teva
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:teva
|
5239
|
Mar 16th, 2024 12:00AM
|
Teva Pharmaceuticals
|
1.1M
|
27852
|
Open
|
|
Mar 16th, 2024 01:58AM
|
Mar 16th, 2024 08:46PM
|
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/
|
Open
|
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
|
Open
|
124 Dvora hanevi'a
|
Tel-Aviv
|
|
IL
|
6944020
|
|
Teva
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:teva
|
5239
|
Mar 15th, 2024 12:00AM
|
Teva Pharmaceuticals
|
1.1M
|
27852
|
Open
|
|
Mar 15th, 2024 08:52AM
|
Mar 15th, 2024 10:39AM
|
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/
|
Open
|
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
|
Open
|
124 Dvora hanevi'a
|
Tel-Aviv
|
|
IL
|
6944020
|
|
Teva
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:teva
|
5239
|
Mar 14th, 2024 12:00AM
|
Teva Pharmaceuticals
|
1.1M
|
27854
|
Open
|
|
Mar 14th, 2024 03:17AM
|
Mar 14th, 2024 02:03PM
|
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/
|
Open
|
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
|
Open
|
124 Dvora hanevi'a
|
Tel-Aviv
|
|
IL
|
6944020
|
|
Teva
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:teva
|
5239
|
Mar 13th, 2024 12:00AM
|
Teva Pharmaceuticals
|
1.1M
|
27842
|
Open
|
|
Mar 13th, 2024 01:22AM
|
Mar 13th, 2024 12:31PM
|
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/
|
Open
|
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
|
Open
|
124 Dvora hanevi'a
|
Tel-Aviv
|
|
IL
|
6944020
|
|
Teva
|
Health Care
|
Pharmaceuticals & Biotechnology
|